2023 Assisted Circulation Gordon Research Conference and Seminar

项目摘要-辅助循环戈登研究会议（GRC）是一个半年一次的会议 由来自国际各地的特邀演讲者、讨论负责人和参与者组成的多元化团体- 公认的临床医生、工程师和科学家开创了机械循环支持（MCS）领域 及相关学科。我们的GRC计划委员会已经制定了一个为期一周的计划， 我们的下一个辅助循环GRC将于5月28日至6月2日在新罕布什尔州的沃特维尔山谷举行， 2023.我们全面的GRC计划的重点是MCS的最新发展 领域，包括以前未发表的数据，临床和科学循证研究的介绍 和开发活动，并引入影响MCS治疗未来的新概念， 旨在改善心力衰竭（HF）患者的预后并恢复其生活质量。特邀演讲嘉宾为 MCS领域和相关学科的先驱，将展示他们的突破性研究， 关键需求领域的发展。讨论主持人将促进并积极吸引观众 参与，鼓励公开和互动的概念和想法的交流是挑衅性的， 刺激以促进和快速加速MCS治疗的进展。GRC参与者将 由多学科（临床，工程，科学），多机构（学术，工业，医院， 政府）和多种多样（职业阶段，种族，性别，地域）的参与者由GRC裁定 和计划委员会是包容性的，代表了广泛的经验，专业知识，想法， 无偏见的前瞻性。我们的GRC项目委员会正在申请补充资金（10,000美元预算）， 特别是为10名来自不同背景的早期受邀演讲者提供差旅相关费用 （妇女和/或非白人）在MCS领域或相关学科。GRC的主要目标是 循环将解决并实现以下目标：（1）确定最佳临床实践 并提供创造性的方法，以实现共识和协调MCS中心之间的最佳实践， 医疗保健提供者;（2）审查新型MCS器械技术的最新进展， 在该领域的破坏性或革命性的想法，以及突出"概念思维"会议，其中GRC 参与者可以为开发新的设备设计或解决问题的创新方法做出贡献; （3）突出基础科学的新发现和将这些发现转化为 最佳做法，包括人类生物学以及与人类活动有关的人类生物学变化和适应 MCS器械治疗的存在。所有与会者（特邀演讲者， 讨论领导者、参与者）评估项目质量以及是否成功实现了目标，以及 计划委员会将完成一份总结报告，突出重点领域的需求，并建立最佳 实践标准。

Project Summary – The Gordon Research Conference (GRC) on Assisted Circulation is a bi-annual meeting consisting of a diverse group of invited speakers, discussion leaders, and participants who are internationally- recognized clinicians, engineers, and scientists pioneering the field of mechanical circulatory support (MCS) and related disciplines. Our GRC program committee has developed a one-week program in preparation for our next GRC on Assisted Circulation to be held in in Waterville Valley, New Hampshire from May 28 - June 2, 2023. The focus of our comprehensive GRC program is on the latest emerging developments in the MCS field, including the presentation of previously unpublished data, clinical and scientific evidence-based research and development activities, and introducing novel concepts that impact the future of MCS therapy and are designed to improve heart failure (HF) patient outcomes and restore their quality of life. Invited speakers are pioneers in the MCS field and related disciplines that will present their ground-breaking research and development in critical areas of need. Discussion leaders will promote and actively engage audience participation to encourage open and interactive exchange of concepts and ideas that are provocative and stimulating to facilitate and rapidly accelerate advancement of MCS therapy. GRC participants will be comprised of multi-disciplinary (clinical, engineering, science), multi-institutional (academic, industry, hospital, government), and multi-diversity (career-stage, ethnic, gender, geographical) participants adjudicated by GRC and Program Committee to be inclusive and representative of wide-range of experience, expertise, ideas, and unbiased prospective. Our GRC program committee is requesting supplemental funding ($10,000 budget), specifically to support travel-related expenses for ten early-stage invited speakers of diverse background (women and/or non-white) in the MCS field or related discipline. The primary goal of the GRC on Assisted Circulation will be to address and achieve each of the following objectives: (1) identify best clinical practices and provide inventive methods to achieve consensus and harmonize best practices among MCS centers and health care providers; (2) review the latest advancements in novel MCS device technologies that represent disruptive or revolutionary ideas in the field as well as highlight a "conceptual thinking" session, where GRC participants can contribute to the development of novel device designs or innovative ways of problem solving; and (3) highlight novel basic science discoveries and innovative methods to translate these discoveries into best practices, including human biology and the changes and adaptation of the human biology associated with the presence of MCS device therapy. GRC surveys will be completed by all attendees (invited speakers, discussion leaders, participants) to assess program quality and whether objectives were successfully met, and the program committee will complete a summary report highlighting critical areas of need and establishing Best Practices criteria.